TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common stock, $0.001 par value
Symbol
TMCI on Nasdaq
Shares outstanding
63,223,223
Price per share
$2.45
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
38,823,239
Total reported value
$260,292,696
% of total 13F portfolios
0%
Share change
+327,524
Value change
+$3,224,803
Number of holders
117
Price from insider filings
$2.45
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% +0.7% $42,382,886 +$704,592 6,316,000 +1.7% Armistice Capital, LLC 30 Sep 2025
GAGNON SECURITIES LLC 6.3% $30,283,645 3,979,454 Neil Gagnon 09 May 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 5.8% $24,590,073 3,664,472 WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 30 Sep 2025
MORGAN STANLEY 3.4% $15,918,666 2,091,809 Morgan Stanley 31 Dec 2024

As of 30 Sep 2025, 117 institutional investors reported holding 38,823,239 shares of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI). This represents 61% of the company’s total 63,223,223 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 10% 6,316,000 +0.89% 1.3% $42,380,360
BlackRock, Inc. 5.8% 3,682,660 -2.2% 0% $24,710,649
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 5.7% 3,634,381 +17% 0.06% $24,386,697
VANGUARD GROUP INC 4.3% 2,731,480 +0.23% 0% $18,328,230
GAGNON SECURITIES LLC 3.6% 2,258,238 +0.36% 3% $15,152,777
MILLENNIUM MANAGEMENT LLC 2.7% 1,710,140 +13% 0.01% $11,475,039
CIBC Private Wealth Group LLC 2.7% 1,686,521 -0.06% 0.02% $11,316,556
JPMORGAN CHASE & CO 2.6% 1,613,532 -9.2% 0% $10,826,800
First Eagle Investment Management, LLC 2% 1,238,895 +36% 0.02% $8,312,985
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,146,407 +2.4% 0% $7,693,691
STATE STREET CORP 1.6% 991,841 +0.59% 0% $6,655,253
Gagnon Advisors, LLC 1.5% 968,464 +17% 4% $6,498,393
DEUTSCHE BANK AG\ 1.5% 931,818 +0.68% 0% $6,252,499
Parkman Healthcare Partners LLC 1.3% 847,675 +0.44% 0.62% $5,687,899
D. E. Shaw & Co., Inc. 1.2% 761,333 -7.5% 0% $5,108,544
MORGAN STANLEY 1.2% 760,309 -25% 0% $5,101,673
Opaleye Management Inc. 1.1% 702,245 0.67% $4,712,064
CenterBook Partners LP 1.1% 674,370 +20% 0.22% $4,525,023
NORTHERN TRUST CORP 0.68% 432,233 -0.63% 0% $2,900,283
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.66% 415,006 +17% 0% $2,784,690
Acuitas Investments, LLC 0.48% 301,100 1.3% $2,020,381
UBS Group AG 0.45% 283,349 -25% 0% $1,901,272
ACADIAN ASSET MANAGEMENT LLC 0.43% 271,937 +92% 0% $1,822,000
PARADIGM CAPITAL MANAGEMENT INC/NY 0.4% 250,000 -6.8% 0.07% $1,677,500
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.39% 249,332 +0.07% 0% $1,495,992

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 284,340 $810,625 -$67,362 $2.45 7
2025 Q3 38,823,239 $260,292,696 +$3,224,803 $6.71 117
2025 Q2 38,411,285 $225,932,843 +$594,569 $5.88 122
2025 Q1 37,892,233 $314,933,189 +$6,396,334 $8.39 136
2024 Q4 37,307,543 $277,764,983 -$12,775,671 $7.44 133
2024 Q3 39,247,446 $227,585,037 +$79,738 $5.80 132
2024 Q2 39,677,902 $263,892,051 -$72,766,025 $6.65 126
2024 Q1 40,836,109 $531,892,030 -$2,988,891 $13.05 127
2023 Q4 34,533 $440,296 -$2,778,835 $12.75 2
2023 Q3 38,319,956 $502,356,099 -$36,752,238 $13.11 123
2023 Q2 38,053,058 $973,207,097 +$63,021,790 $25.58 134
2023 Q1 35,532,928 $895,083,156 +$184,122,683 $25.19 121
2022 Q4 26,856,767 $617,440,501 +$43,975,741 $22.99 103
2022 Q3 26,091,450 $575,834,130 +$73,545,855 $22.07 89
2022 Q2 23,068,538 $330,510,611 +$38,312,556 $14.34 79
2022 Q1 20,370,513 $385,285,843 -$166,979,987 $18.91 75
2021 Q4 17,228,093 $320,930,460 +$66,992,546 $18.64 75
2021 Q3 13,036,811 $350,677,095 -$6,969,422 $26.90 62
2021 Q2 13,009,799 $406,683,468 +$406,677,614 $31.26 70
2021 Q1 179 $6,000 $0 $33.52 1
2020 Q4 179 $6,000 $0 $33.52 1
2020 Q3 179 $6,000 $0 $33.52 1
2020 Q2 179 $6,000 $0 $33.52 1
2020 Q1 179 $6,000 $0 $33.52 1
2019 Q4 179 $6,000 $0 $33.52 1
2019 Q3 179 $6,000 $0 $33.52 1
2019 Q2 179 $6,000 $0 $33.52 1
2019 Q1 179 $6,000 $0 $33.52 1